News
AstriVax begins clinical development of AVX70371, a hepatitis B immunotherapy using Launch-iT technology: Leuven, Belgium Saturday, June 7, 2025, 10:00 Hrs [IST] AstriVax Therapeu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback